Tumour-infiltrating lymphocyte therapy in melanoma: ready for prime time?
Saved in:
| Title: | Tumour-infiltrating lymphocyte therapy in melanoma: ready for prime time? |
|---|---|
| Authors: | Woodford R; Advanced Immunotherapy & Cell Therapy Team, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; National Health and Medical Research Council Clinical Trials Unit, University of Sydney, Camperdown, NSW, Australia., Lorigan P; Melanoma Team, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Oudit D; Plastic Surgery Team, Department of Surgery, The Christie NHS Foundation Trust, Manchester, UK., Abdulgawad A; Cellular Therapies & Early Phase Trials Team, Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK., Thistlethwaite F; Advanced Immunotherapy & Cell Therapy Team, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Lim KHJ; Advanced Immunotherapy & Cell Therapy Team, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. jon.lim@manchester.ac.uk.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. jon.lim@manchester.ac.uk. |
| Source: | British journal of cancer [Br J Cancer] 2026 Jun; Vol. 134 (11), pp. 1501-1509. Date of Electronic Publication: 2026 Feb 18. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41708938 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tumour-infiltrating lymphocyte therapy in melanoma: ready for prime time? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Woodford+R%22">Woodford R</searchLink>; Advanced Immunotherapy & Cell Therapy Team, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; National Health and Medical Research Council Clinical Trials Unit, University of Sydney, Camperdown, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Lorigan+P%22">Lorigan P</searchLink>; Melanoma Team, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Oudit+D%22">Oudit D</searchLink>; Plastic Surgery Team, Department of Surgery, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Abdulgawad+A%22">Abdulgawad A</searchLink>; Cellular Therapies & Early Phase Trials Team, Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Thistlethwaite+F%22">Thistlethwaite F</searchLink>; Advanced Immunotherapy & Cell Therapy Team, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Lim+KHJ%22">Lim KHJ</searchLink>; Advanced Immunotherapy & Cell Therapy Team, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. jon.lim@manchester.ac.uk.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. jon.lim@manchester.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2026 Jun; Vol. 134 (11), pp. 1501-1509. <i>Date of Electronic Publication: </i>2026 Feb 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41708938 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41416-026-03350-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1501 Titles: – TitleFull: Tumour-infiltrating lymphocyte therapy in melanoma: ready for prime time? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Woodford R – PersonEntity: Name: NameFull: Lorigan P – PersonEntity: Name: NameFull: Oudit D – PersonEntity: Name: NameFull: Abdulgawad A – PersonEntity: Name: NameFull: Thistlethwaite F – PersonEntity: Name: NameFull: Lim KHJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1532-1827 Numbering: – Type: volume Value: 134 – Type: issue Value: 11 Titles: – TitleFull: British journal of cancer Type: main |
| ResultId | 1 |
